AWRE AWARE INC /MA/ Insider Trading

AWRE CEO Amlani buys 9,826 shares at $1.42; stock -51.9% from 52-week high of $2.95.

Ajay K Amlani, President & CEO, purchased 9,826 shares at $1.42 on 2026-06-12, bringing his post-transaction holdings to 923,837 shares. The current price of $1.42 is -51.9% from the 52-week high of $2.95, though the stock has risen +11.8% over the past 30 days and +8.4% over 90 days. His prior trades at AWRE show mixed near-term outcomes: two buys from mid-May posted 30-day gains of +16.0% and +19.8%, though the company remains unprofitable with a net income of $-3.5M in its most recent full fiscal year. The significance of this purchase is tempered by the company's negative fundamentals and the absence of measurable long-term timing patterns at this ticker.

CEO Ajay K Amlani purchased 10,763 shares for $13,328.49 across 3 transactions, raising stake to 914,011 shares amid stock down 24.0% in 90 days.

Ajay K Amlani, President & CEO of AWARE INC, executed 3 separate purchases totaling 10,763 shares for $13,328.49 (blended average $1.24) between May 21–26, 2026, increasing his holdings to 914,011 shares (+1.2% vs pre-transaction). The stock trades at $1.30, down 24.0% over 90 days and 55.9% below its 52-week high of $2.95, reflecting significant price pressure. Company fundamentals show instability: net income was $-3.5M in the latest quarter and negative over the full prior fiscal year, with revenue essentially flat year-over-year ($3.4M in Q). His same-ticker buying pattern at AWRE shows mixed results (1 of 3 measurable prior buys well-timed at the 90-day mark), and at the cross-ticker level his average 90-day return on buys is +10.1% with a 58.33% win rate, though neither metric directly predicts outcomes for this ticker's structural challenges. The accumulation during a steep drawdown merits investor monitoring of whether the CEO's conviction reflects company stabilization plans or simply opportunistic purchasing amid depressed valuation.

AWRE CEO Ajay K Amlani buys 10,874 shares ($13,563.14) over 2 days at $1.21–$1.25; 5th purchase in 2 weeks despite -$3.5M quarterly loss

Amlani purchased 10,874 shares in two separate transactions on 2026-05-14 and 2026-05-15 at a blended average price of $1.25, increasing his holdings from 892,374 to 903,248 shares. This marks his fifth open-market purchase at AWRE within the past two weeks (following buys on 2026-05-08, 2026-05-05, 2026-05-04, and 2026-05-01), establishing a pattern of consistent accumulation. The company reported a net loss of $3,458,000.00 in the latest quarter, with annual revenue declining 0.6% year-over-year and the company remaining unprofitable on a full-year basis. The repeated purchases at depressed price levels ($1.21–$1.25) by the CEO during a period of operational losses merit examination, as they may reflect either conviction in a turnaround plan or execution of a predetermined trading schedule; without additional context on strategic initiatives or guidance, the timing pattern offers limited visibility into management's confidence in near-term recovery.

Director John S Iii Stafford accumulates 80,412 shares at $1.25 at depressed valuation; stock down -59.0% from 52-week high amid unprofitable operations.

Director John S Iii Stafford purchased 80,412 shares across two consecutive days (2026-05-13 and 2026-05-14) at $1.25 per share for a total of $100,515.00, expanding his holdings to 5,221,954 shares. The purchases occurred near a 52-week low relative to the $2.95 peak, with the stock currently trading at $1.21 (-59.0% from highs) and down 30.1% over the past 90 days. However, the company's fundamentals remain challenged: revenue is $3.4M, net income is -$3.5M (unprofitable), and market cap is only $26.2M. His prior trades at AWRE show mixed execution: of the two measurable same-ticker trades, only 1 of 2 demonstrated positive 90-day outcomes. The timing of these purchases near depressed valuations and the director's substantial incremental stake (1.56% increase) suggest conviction at current prices, but the company's ongoing losses and poor prior timing at this ticker (1 of 2 well-timed at 90-day horizon) warrant scrutiny into whether this reflects genuine operational optimism or simply accumulation at rock-bottom levels.

CEO Ajay Amlani purchases shares while stock trades well below 52-week high; repeat buyer and 11th open-market purchase in 36 months.

Ajay Amlani, President and CEO of Aware Inc, acquired shares at prices well below the 52-week high, taking his most recent step in a consistent pattern of open-market purchases over the past three years. The stock currently trades significantly below its recent peak and is down over the longer term, creating a backdrop where the insider's repeated buying stands out—this is his 11th open-market purchase in the 36-month window. However, the company itself faces material headwinds: revenues are declining year-over-year, the firm is unprofitable with negative quarterly earnings, and fundamentals suggest operational stress. Amlani's prior five trades at this ticker are too recent to have generated measurable outcomes, so we cannot yet assess whether his recent buying pattern has been well-timed or misjudged. The persistent buying despite deteriorating financial performance and a depressed stock price warrants close observation of whether the CEO's conviction translates into operational improvements or represents accumulation during a further decline.

Director John S Stafford buys nearly 20K shares at depressed prices as stock falls sharply and company faces ongoing losses.

John S Stafford, a director at Aware Inc, purchased nearly 20,000 shares across two trading days at the same price, deploying roughly $24,500 into a company trading well below its annual highs amid a significant decline over the past quarter. This is his third purchase in this stock—he has bought twice before with mixed results, as his most recent buy saw the stock soften afterward, while an earlier purchase's outcome remains too recent to assess. The company is unprofitable with revenue essentially flat year-over-year, and the stock's sharp price drop suggests market skepticism about Aware's near-term trajectory. Stafford's willingness to buy into a weakened stock and struggling business fundamentals suggests either conviction in a longer-term turnaround or an attempt to average down from a prior position—though his track record offers limited evidence that past buys have been well-timed. The modest size of these purchases relative to his overall holdings indicates this is a meaningful but not portfolio-altering move.

AWRE CEO Amlani purchases 15,000 shares as stock trades well below highs; company unprofitable with declining fundamentals.

Ajay K Amlani, the company's President and CEO, purchased 15,000 shares at a time when the stock is trading significantly below its recent highs and has declined over the preceding quarter, suggesting he is buying into weakness rather than riding momentum. His insider track record consists entirely of purchases with no sales—he has repeatedly bought this same stock within the past year, though those recent acquisitions are too new to evaluate their outcomes. The company's fundamentals present a challenging backdrop: the business is unprofitable with declining revenue, yet Amlani continues to accumulate shares, implying conviction in a turnaround or belief that current weakness represents opportunity. As CEO, Amlani has direct operational knowledge of the company's trajectory and challenges, making his continued buying pattern noteworthy even in a financially struggling business.

CEO Ajay Amlani buys ~30k shares across two transactions as stock trades well below 52-week highs; company remains unprofitable with declining fundamentals.

Ajay Amlani, President and CEO of Aware Inc, purchased approximately 30,000 shares across two open-market transactions in early May, adding to his stake while the stock trades well below its 52-week high and near the lower end of its recent range. This marks the tenth and eleventh open-market purchases by Amlani in the past three years, demonstrating a persistent pattern of buying; however, none of his five prior purchases at this same ticker have yet reached a measurable outcome, so we cannot assess whether his previous buying decisions proved well-timed. The company's fundamentals remain under pressure—revenues are declining year-over-year and the business is unprofitable on both an annual and quarterly basis—creating a backdrop where a CEO's open-market purchases amid weakness could signal conviction or simply reflect regular portfolio management at a time of operational difficulty. Amlani already holds a substantial stake, and this accumulation modestly increases his ownership position. The timing of these purchases, following a quarter-long pullback, positions the accumulation within a typical window for insider buying, though without visibility into outcome data from his prior trades at this ticker, the significance of this buying pattern remains incompletely clear.

CFO Traverse David K bought 4,500 shares of AWRE at $1.15 on 2026-03-17, raising holdings to 61.0K shares; stock down 60.2% from 52-week high.

CFO David K Traverse purchased 4,500 shares at $1.15 on 2026-03-17, increasing his position by 8.0% to 61.0K shares total. The timing is notable: his prior 4 measurable buys at AWRE showed 3 of 4 well-timed at the 90-day mark (with outcomes ranging from +2.0% to +33.3%), suggesting a pattern of purchasing near interim lows. However, AWRE's fundamentals are materially weak—the company is unprofitable (net income $-1.1M in the latest quarter), revenues are essentially flat year-over-year (-0.6%), and the stock has collapsed 60.2% from its 52-week high and is down 32.4% over the past 30 days. The CFO's buy sits in the context of severe price deterioration and an unprofitable business, which constrains the bullish signal even if his historical timing at this ticker has been sound.

Director Stafford John S III bought 16,754 shares at $1.28 on 2026-03-13; stock now at $1.17, down 60.2% from 52-week high.

Director John Stafford III purchased 16,754 shares at $1.28 on March 13, 2026, adding to a substantial existing position of 5.12M shares. The stock has declined 32.4% over the past 30 days and is trading at $1.17, down 60.2% from its 52-week high of $2.94. Fundamentally, the company reported quarterly revenue of $5,129,000.00 with a net loss of $-1,053,000.00 and negative full-year profitability, signaling financial stress. While Stafford's prior buy at this ticker in March 2025 demonstrated a 90-day gain of 3.0%, the current trading environment presents elevated downside risk given the sharp price deterioration, substantial losses, and overall negative trajectory.